Prognostic role of non-sustained ventricular tachycardia in a large cohort of patients with idiopathic dilated cardiomyopathy

Italian Heart Journal

Volumn 6, Issue 9, 2005, Pages 721-727

  Zecchin, Massimo ^a,d   Di Lenarda, Andrea ^a   Gregori, Dario ^b   Moretti, Michele ^a   Driussi, Mauro ^a   Aleksova, Aneta ^a   Chersevani, Dorita ^c   Sabbadini, Gastone ^a   Sinagra, Gianfranco ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c Civic Hospital   (Italy)

^d Ospedali Riuniti Polo Cardiologico   (Italy)

Author keywords

Dilated cardiomyopathy; Prognosis; Sudden cardiac death; Ventricular tachycardia

Indexed keywords

ADULT; ARTICLE; CONGESTIVE CARDIOMYOPATHY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HEART STROKE VOLUME; HEART VENTRICLE TACHYCARDIA; HUMAN; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL;

ADULT; CARDIOMYOPATHY, DILATED; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY, AMBULATORY; FOLLOW-UP STUDIES; HUMANS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STROKE VOLUME; SURVIVAL ANALYSIS; TACHYCARDIA, VENTRICULAR; VENTRICULAR DYSFUNCTION, LEFT;

EID: 33744760564     PISSN: 1129471X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Bänsch D, Antz M, Boczor S, et al. Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy. The Cardiomyopathy Trial (CAT). Circulation 2002; 105: 1453-8.
2. Strickberger SA, Hummel JD, Bartlett TG, et al, for the AMIOVIRT Investigators. Amiodarone Versus Implantable Cardioverter-Defibrillator: randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia - AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707-12.
3. Kadish A, Dyer A, Daubert JP, et al, for the Defibrillators in Non-Ischemic Cardiomyopathy Treatment Evaluation (DEFINITE) Investigators. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-8.
4. Bardy GH, Lee KL, Mark DB, et al, for the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 302: 225-37.
5. Grimm W, Christ M, Bach J, Müller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: results of the Marburg Cardiomyopathy Study. Circulation 2003; 108: 2883-91.
6. Holmes J, Kubo S, Cody R, Kligfield P. Arrhythmias in ischemic and nonischemic cardiomyopathy: prediction of mortality by ambulatory electrocardiography. Am J Cardiol 1985; 55: 146-51.
7. Meinertz T, Hofmann T, Kasper W, et al. Significance of ventricular arrhythmias in idiopathic dilated cardiomyopathy. Am J Cardiol 1984; 53: 902-7.
8. von Olshausen K, Schäfer A, Mehmel HC, Schwarz F, Senges J, Küber W. Ventricular arrhythmias in idiopathic dilated cardiomyopathy. Br Heart J 1984; 51: 195-201.
9. Huang SK, Messer JV, Denes P. Significance of ventricular tachycardia in idiopathic dilated cardiomyopathy: observations in 35 patients. Am J Cardiol 1983; 51: 507-12.
10. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the definition and classification of cardiomyopathies. Circulation 1996; 93: 841-2.
11. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.
12. The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severe congestive heart failure: results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS). N Engl J Med 1987; 316: 1429-35.
13. Zecchin M, Di Lenarda A, Bonin M, et al. Incidence and predictors of sudden cardiac death during long-term follow-up in patients with dilated cardiomyopathy on optimal medical therapy. Ital Heart J 2001; 2: 213-22.
14. Zecchin M, Di Lenarda A, Proclemer A, et al. The role of implantable cardioverter defibrillator for primary vs secondary prevention of sudden death in patients with idiopathic dilated cardiomyopathy. Europace 2004; 6: 400-6.
15. Buxton AE, Lee KL, Hafley GE, et al, for the MUSTT Investigators. Relation of ejection fraction and inducible ventricular tachycardia to mode of death in patients with coronary artery disease. An analysis of patients enrolled in the Multicenter Unsustained Tachycardia Trial. Circulation 2002; 106: 2466-72.
16. Moss AJ, Zareba W, Hall WJ, et al, for the Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-83.
17. Luu M, Stevenson WG, Stevenson LW, Baron K, Walden J. Diverse mechanisms of unexpected cardiac arrest in advanced heart failure. Circulation 1989; 80: 1675-80.
18. Pogwizd SM, McKenzie JP, Cain ME. Mechanisms underlying spontaneous and induced ventricular arrhythmias in patients with idiopathic dilated cardiomyopathy. Circulation 1998; 98: 2404-14.
19. Di Lenarda A, Gregori D, Sinagra G, et al. Metoprolol in dilated cardiomyopathy: is it possible to identify factors predictive of improvement? The Heart Muscle Disease Study Group. J Card Fail 1996; 2: 87-102.
20. Di Lenarda A, Hlede S, Sabbadini G, et al. Improvement of prognosis in idiopathic dilated cardiomyopathy: role of early diagnosis and optimized medical treatment. Study Group on Heart Muscle Diseases. G Ital Cardiol 1999; 29: 1452-62.
21. Stewart RA, McKenna WJ, Oakley CM. Good prognosis for dilated cardiomyopathy without severe heart failure or arrhythmia. QJM 1990; 74: 309-18.
22. Doval HC, Nul DR, Grancelli HO, et al. Nonsustained ventricular tachycardia in severe heart failure: independent marker of increased mortality due to sudden death. GESICA-GEMA Investigators. Circulation 1996; 94: 3198-203.
23. Singh SN, Fisher SG, Carson PE, Fletcher RD. Prevalence and significance of nonsustained ventricular tachycardia in patients with premature ventricular contractions and heart failure treated with vasodilator therapy. Department of Veterans Affairs CHF-STAT Investigators. J Am Coll Cardiol 1998; 32: 942-7.
24. Teerlink JR, Jalaluddin M, Anderson S, et al. Ambulatory ventricular arrhythmias in patients with heart failure do not specifically predict an increased risk of sudden death. PROMISE (Prospective Randomized Milrinone Survival Evaluation) Investigators. Circulation 2000; 101: 40-6.
25. Pedretti R, Etro MD, Laporta A, Braga SS, Carù B. Prediction of late arrhythmic events after acute myocardial infarction from combined use of noninvasive prognostic variables and inducibility of sustained monomorphic ventricular tachycardia. Am J Cardiol 1993; 71: 1131-41.
26. Hohnloser SH, Klingenheben T, Bloomfield D, Dabbous O, Cohen RJ. Usefulness of microvolt T-wave alternans for prediction of ventricular tachyarrhythmic events in patients with dilated cardiomyopathy: results from a prospective observational study. J Am Coll Cardiol 2003; 41: 2220-4.